Unknown

Dataset Information

Exhaled nitric oxide detection for diagnosis of COVID-19 in critically ill patients.


ABSTRACT:

Background

COVID-19 may present with a variety of clinical syndromes, however, the upper airway and the lower respiratory tract are the principle sites of infection. Previous work on respiratory viral infections demonstrated that airway inflammation results in the release of volatile organic compounds as well as nitric oxide. The detection of these gases from patients' exhaled breath offers a novel potential diagnostic target for COVID-19 that would offer real-time screening of patients for COVID-19 infection.

Methods and findings

We present here a breath tester utilizing a catalytically active material, which allows for the temporal manifestation of the gaseous biomarkers' interactions with the sensor, thus giving a distinct breath print of the disease. A total of 46 Intens

SUBMITTER: Exline MC 

PROVIDER: S-EPMC8553051 | biostudies-literature | 2021

REPOSITORIES: biostudies-literature